Ascendis Pharma A (ASND) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ascendis Pharma A (ASND) over the last 4 years, with Q4 2024 value amounting to -$5.76.
- Ascendis Pharma A's Debt to Equity fell 5247.87% to -$5.76 in Q4 2024 from the same period last year, while for Dec 2024 it was -$5.76, marking a year-over-year decrease of 5247.87%. This contributed to the annual value of -$5.76 for FY2024, which is 5247.87% down from last year.
- As of Q4 2024, Ascendis Pharma A's Debt to Equity stood at -$5.76, which was down 5247.87% from -$3.78 recorded in Q4 2023.
- In the past 5 years, Ascendis Pharma A's Debt to Equity registered a high of $2.07 during Q4 2022, and its lowest value of -$5.76 during Q4 2024.
- Its 4-year average for Debt to Equity is -$0.57, with a median of $0.9 in 2022.
- As far as peak fluctuations go, Ascendis Pharma A's Debt to Equity skyrocketed by 164387.14% in 2022, and later crashed by 28236.91% in 2023.
- Over the past 4 years, Ascendis Pharma A's Debt to Equity (Quarter) stood at $0.12 in 2021, then skyrocketed by 1643.87% to $2.07 in 2022, then crashed by 282.37% to -$3.78 in 2023, then crashed by 52.48% to -$5.76 in 2024.
- Its Debt to Equity was -$5.76 in Q4 2024, compared to -$3.78 in Q4 2023 and $2.07 in Q4 2022.